A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Recruiting · NCT07525206 · Registry updated 2026-10-07

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder	Recruiting	Phase 3	2026-10-07		NCT07525206

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AbbVie	340

85 results · Page 1 of 4

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital Of Jiangnan University(Wuxi Fourth People'S Hospital ) /ID# 280200	Wuxi	China	1
Asan Medical Center /ID# 282732	Seoul	South Korea	1
Asklepios Klinik Altona /ID# 279301	Hamburg	Germany	1
Astera Cancer Care /ID# 279532	East Brunswick	United States	1
Athens Medical Center - Psychikon Branch /ID# 279134	Athens	Greece	1
AZ Maria Middelares /ID# 280141	Ghent	Belgium	1
AZ-Delta. /ID# 279329	Roeselare	Belgium	1
Beijing Friendship Hospital /ID# 279766	Beijing	China	1
Beijing Hospital No. 2 /ID# 279666	Beijing	China	1
Blue Ridge Cancer Care - Blacksburg /ID# 280115	Blacksburg	United States	1
CHA Bundang Medical Center /ID# 279589	Seongnam	South Korea	1
Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 279302	Berlin	Germany	1
Chi Mei Medical Center /ID# 279710	Tainan	Taiwan	1
China-Japan Union Hospital /ID# 279801	Changchun	China	1
Chonnam National University Hwasun Hospital /ID# 279787	Hwasun-gun	South Korea	1
City Of Hope - Atlanta /ID# 280017	Newnan	United States	1
City Of Hope - Phoenix /ID# 279450	Goodyear	United States	1
City of Hope National Medical Center /ID# 279449	Duarte	United States	1
Cliniques Universitaires UCL Saint-Luc /ID# 279335	Brussels	Belgium	1
Compass Oncology - Rose Quarter /ID# 280127	Portland	United States	1
Dong-A University Medical Center /ID# 279610	Busan	South Korea	1
Duke University Medical Center /ID# 279322	Durham	United States	1
E-Da Cancer Hospital /ID# 279745	Kaohsiung City	Taiwan	1
First Affiliated Hospital of Shanxi Medical University /ID# 279665	Taiyuan	China	1
Gachon University Gil Medical Center /ID# 279592	Incheon	South Korea	1

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Clinical trials

Organizations

Research sites